CMV disease · solid organ transplant recipients
Extended probably leads to lower CMV disease compared with short‐duration valganciclovir (moderate certainty).
1 finding from 1 review
All‐cause death · solid organ transplant recipients
Extended showed no clear difference in all‐cause death compared with short‐duration valganciclovir (low certainty).
1 finding from 1 review
CMV syndrome · solid organ transplant recipients
Extended probably leads to lower CMV syndrome compared with short‐duration valganciclovir (moderate certainty).
1 finding from 1 review
CMV infection · solid organ transplant recipients
Extended may leads to lower CMV infection compared with short‐duration valganciclovir (low certainty).
1 finding from 1 review
Acute rejection · solid organ transplant recipients
Extended probably leads to lower acute rejection compared with short‐duration valganciclovir (moderate certainty).
1 finding from 1 review
Opportunistic infections · solid organ transplant recipients
Extended showed no clear difference in opportunistic infections compared with short‐duration valganciclovir (low certainty).
1 finding from 1 review
Total treatment‐related adverse effects · solid organ transplant recipients
Extended showed no clear difference in total treatment‐related adverse effects compared with short‐duration valganciclovir (moderate certainty).
1 finding from 1 review
Surgical site infections: liver transplant recipients Time frame: 30 days · solid organ transplant recipients
It is very uncertain whether extended changes surgical site infections: liver transplant recipients Time frame: 30… compared with short duration antibiotics (very low certainty).
1 finding from 1 review
Death (any case) Time frame: 2 to 4 weeks · solid organ transplant recipients
It is very uncertain whether extended changes death (any cause) Time frame: 30 days compared with short duration antibiotics (very low certainty).
1 finding from 1 review
Graft loss including death · solid organ transplant recipients
It is very uncertain whether extended changes graft loss (including death with functioning graft) Time frame: 30… compared with short duration antibiotics (very low certainty).
1 finding from 1 review
UTI · solid organ transplant recipients
It is very uncertain whether extended changes other infection: UTI Time frame: 30 days compared with short duration antibiotics (very low certainty).
1 finding from 1 review
Other infection: septicaemia Time frame: 2 to 6 weeks · solid organ transplant recipients
It is very uncertain whether extended changes other infection: septicaemia Time frame: 30 days compared with short duration antibiotics (very low certainty).
1 finding from 1 review
Other infection: pneumonia Time frame: 30 days · solid organ transplant recipients
It is very uncertain whether extended changes other infection: pneumonia Time frame: 30 days compared with short duration antibiotics (very low certainty).
1 finding from 1 review
Adverse drug reactions · solid organ transplant recipients
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Surgical site infection · solid organ transplant recipients
It is very uncertain whether extended changes surgical site infections* (all) Time frame: 30 days compared with short duration antibiotics (very low certainty).
1 finding from 1 review
Surgical site infections: kidney transplant recipients Time frame: 30 days · solid organ transplant recipients
It is very uncertain whether extended changes surgical site infections: kidney transplant recipients Time frame:… compared with short duration antibiotics (very low certainty).
1 finding from 1 review